Can denosumab be continued in a patient undergoing placement of a dental crown?

Denosumab Can Be Continued for Dental Crown Placement

Yes, it is safe to continue denosumab when placing a dental crown (cap) on a tooth. A dental crown is a non-invasive restorative procedure that does not involve bone manipulation or extraction, and therefore carries minimal to no risk of medication-related osteonecrosis of the jaw (MRONJ).

Understanding the Risk Profile

The concern with denosumab relates specifically to invasive dental procedures that involve bone exposure or manipulation. The evidence clearly distinguishes between procedure types:

Low-Risk Procedures (Crown Placement)

• Dental crowns involve tooth preparation above the gum line
• No bone exposure or surgical manipulation occurs
• No interruption of denosumab is necessary 1, 2

High-Risk Procedures (Requiring Consideration)

The guidelines specifically identify invasive procedures as problematic 1, 3, 4:

• Tooth extractions (MRONJ risk 0.5% with bisphosphonates, 2.3% with denosumab) 1, 5
• Dental implant placement 6
• Oral surgery involving bone

Critical Timing Considerations for Invasive Procedures

While not applicable to crown placement, understanding the timing principles is important for future dental planning:

If invasive dental surgery becomes necessary later:

• Avoid procedures within 3 months of denosumab injection - all MRONJ cases occurred in this window 7
• Optimal timing: 4-7 months after last injection provides maximum protection 7, 5
• The protective effect increases significantly with longer intervals from last dose (OR 0.35, p=0.0089) 7

Why Denosumab Cannot Be Stopped Casually

A critical caveat: Unlike bisphosphonates, denosumab has unique pharmacokinetics that make drug holidays problematic 2:

• Denosumab does not accumulate in bone tissue
• Stopping causes rapid rebound in bone turnover within weeks
• Risk of multiple vertebral fractures increases after discontinuation 1, 2, 8
• Bone mineral density decreases 6.6% (lumbar spine) and 5.3% (total hip) within 12 months of stopping 1

This rebound phenomenon means that interrupting denosumab for a non-invasive procedure like crown placement would cause more harm than benefit.

Practical Management Algorithm

For this patient receiving a crown:

1. Continue denosumab on schedule - no modification needed
2. Ensure good oral hygiene practices
3. No special precautions required beyond routine dental care

For future invasive procedures (if needed):

1. Schedule extractions/implants 4-7 months after last denosumab dose when possible 7
2. Defer next denosumab dose until complete mucosal healing confirmed by dentist 2, 3, 4
3. Use prophylactic antibiotics for extractions 2
4. Ensure primary wound closure with proper surgical technique 9
5. Never stop denosumab indefinitely - transition to bisphosphonate if prolonged delay needed 1, 2

Common Pitfalls to Avoid

• Do not confuse crown placement with extraction - these carry vastly different risks
• Do not implement unnecessary drug holidays - the fracture risk from stopping denosumab (particularly vertebral fractures) far exceeds any theoretical benefit for non-invasive procedures 2
• Do not assume bisphosphonate guidelines apply to denosumab - the pharmacokinetics differ fundamentally 2

The FDA label explicitly states that dental examination with preventive dentistry is recommended before initiating treatment in high-risk patients, and emphasizes avoidance of invasive dental procedures during therapy 8. Crown placement does not meet the definition of an invasive procedure requiring special consideration.